BRK-B vs JPC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
JPC exhibits a stable financial profile with a Piotroski F-Score of 6/9 and trades at a significant discount to its Graham Number of $12.82. While the fund shows strong historical performance (64.1% over 3 years) and a highly attractive P/E ratio of 8.82 compared to the sector average of 35.45, it is hampered by a bearish technical trend and weak insider sentiment. The valuation is anchored by a Price/Book ratio of 0.98, suggesting the asset is priced fairly relative to its net asset value, though the intrinsic growth-based value is lower at $6.30.
Compare Another Pair
Related Comparisons
BRK-B vs JPC: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Nuveen Preferred & Income Opportunities Fund (JPC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.